New York Times Report on Vision Therapy
< Back to Previous PageAn article about vision therapy in The New York Times has created a good deal of debate and discussion. By the time comments were no longer being accepted, six days after the article was published online, there were 248 comments.
As you read through many of the comments, you can easily see where the line was being drawn in this debate. On one side are the many patient, parents, and behavioral optometrists who see lives changing because vision therapy is an effective treatment for so many patients. On the other side are the skeptics, who have had no experience with vision therapy and can only say, “Where is the evidence?”
Evidence-Based Medicine
Evidence-based medicine is defined as the “conscientious explicit and judicious use of current best evidence in making decisions about the care of individual patients.” The process of evidence-based medicine BEGINS with the interpretation of clinically relevant research. It ENDS with the careful consideration of all relevant information for an individual patient. Evidence-based medicine has the potential to improve the clinical outcomes for patients with any diagnosis. However, the impact of evidence-based medicine is limited by the difficulty of getting from the BEGINNING to the END. This is where Clinical Practice Guidelines have become so important in bridging that gap.
Read More About this Report and the Response by COVD
As you read through many of the comments, you can easily see where the line was being drawn in this debate. On one side are the many patient, parents, and behavioral optometrists who see lives changing because vision therapy is an effective treatment for so many patients. On the other side are the skeptics, who have had no experience with vision therapy and can only say, “Where is the evidence?”
Evidence-Based Medicine
Evidence-based medicine is defined as the “conscientious explicit and judicious use of current best evidence in making decisions about the care of individual patients.” The process of evidence-based medicine BEGINS with the interpretation of clinically relevant research. It ENDS with the careful consideration of all relevant information for an individual patient. Evidence-based medicine has the potential to improve the clinical outcomes for patients with any diagnosis. However, the impact of evidence-based medicine is limited by the difficulty of getting from the BEGINNING to the END. This is where Clinical Practice Guidelines have become so important in bridging that gap.
Read More About this Report and the Response by COVD
